Western blot analysis indicated that transfection with miR98, but not the mock or negative control, inhibited the activation of the N-Ras/ERK/PI3K/NFκB/Lin28b signaling pathway induced by CCL18 in breast cancer cells (Figure 4E). Here, NFKB1 is linked to breast cancer.